Literature DB >> 10787385

Alcohol and porphyrin metabolism.

M O Doss1, A Kühnel, U Gross.   

Abstract

Alcohol is a porphyrinogenic agent which may cause disturbances in porphyrin metabolism in healthy persons as well as biochemical and clinical manifestations of acute and chronic hepatic porphyrias. After excessive consumption of alcohol, a temporary, clinically asymptomatic secondary hepatic coproporphyrinuria is observable, which can become persistent in cases of alcohol-induced liver damage. Nowadays, the alcohol-liver-porphyrinuria syndrome is the first to be mentioned in secondary hepatic disturbances of porphyrin metabolism. Acute hepatic porphyrias (acute intermittent porphyria, variegate porphyria and hereditary coproporphyria) are considered to be molecular regulatory diseases, in contrast to non-acute, chronic hepatic porphyria, clinically appearing as porphyria cutanea tarda (PCT). Porphyrins do not accumulate in the liver in acute porphyrias, whereas in chronic hepatic porphyrias they do. Thus, chronic hepatic porphyria is a porphyrin-accumulation disease, whereas acute hepatic porphyrias are haem-pathway-dysregulation diseases, characterized in general by induction of delta-aminolevulinic acid synthase in the liver and excessive stimulation of the pathway without storage of porphyrins in the liver. The clinical expression of acute hepatic porphyrias can be triggered by alcohol, because alcohol augments the inducibility of delta-aminolevulinic acid synthase. In chronic hepatic porphyrias, however, which are already associated with liver damage, alcohol potentiates the disturbance of the decarboxylation of uro- and heptacarboxyporphyrinogen, which is followed by a hepatic accumulation of uro- and heptacarboxyporphyrin and their sometimes extreme urinary excretion. Especially in persons with a genetic deficiency of uroporphyrinogen decarboxylase, but also in patients with the so-called sporadic variety of PCT, alcohol is able to transform an asymptomatic coproporphyrinuria into PCT. Alcohol has many biochemical and clinical effects on porphyrin and haem synthesis both in humans and laboratory animals. Ethanol suppresses the activity of porphobilinogen synthase (synonym: delta-aminolevulinic acid dehydratase), uroporphyrinogen decarboxylase, coproporphyrinogen oxidase and ferrochelatase, whereas it induces the first and rate-limiting enzyme in the pathway, delta-aminolevulinic acid synthase and also porphobilinogen deaminase. Therefore, teetotalism is a therapeutically and prophylactically important measure in all types of hepatic porphyrias.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787385     DOI: 10.1093/alcalc/35.2.109

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  8 in total

Review 1.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

2.  [Acute intermittent porphyria. A clinical chameleon: case study of a 40-year-old female patient].

Authors:  M Zimmermann; C Bonaccurso; C Valerius; G F Hamann
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

3.  Self-rated psychosocial consequences and quality of life in the acute porphyrias.

Authors:  L M Millward; P Kelly; A Deacon; V Senior; T J Peters
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

Review 4.  Recent advances in photodynamic diagnosis of gastric cancer using 5-aminolevulinic acid.

Authors:  Noriaki Koizumi; Yoshinori Harada; Takeo Minamikawa; Hideo Tanaka; Eigo Otsuji; Tetsuro Takamatsu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 5.  Acute hepatic porphyria and anaesthesia: a practical approach to the prevention and management of acute neurovisceral attacks.

Authors:  N Wilson-Baig; M Badminton; D Schulenburg-Brand
Journal:  BJA Educ       Date:  2020-12-09

Review 6.  Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell Injury.

Authors:  Dhiman Maitra; Juliana Bragazzi Cunha; Jared S Elenbaas; Herbert L Bonkovsky; Jordan A Shavit; M Bishr Omary
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-06-21

7.  Urinary porphyrin excretion in children is associated with exposure to organochlorine compounds.

Authors:  Jordi Sunyer; Mar Alvarez-Pedrerol; Jordi To-Figueras; Núria Ribas-Fitó; Joan O Grimalt; Carmen Herrero
Journal:  Environ Health Perspect       Date:  2008-06-05       Impact factor: 9.031

8.  Porphyria: What Is It and Who Should Be Evaluated?

Authors:  Yonatan Edel; Rivka Mamet
Journal:  Rambam Maimonides Med J       Date:  2018-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.